new mexico department of health

New Mexico: Dept. of Health Awards Medical Cannabis Software Contract

BioTrackTHC

The New Mexico Department of Health's Medical Cannabis Program has awarded BioTrackTHC™, a division of Bio-Tech Medical Software, Inc., a contract for the provision and deployment of an integrated patient and provider tracking software application.

This makes BioTrackTHC the cannabis industry's first company with marijuana regulatory technology contracts in two states, according to a company press release, following the company's existing contract for the state of Washington's Marijuana Seed-to-Sale Traceability System.

"I commend the New Mexico Department of Health on its comprehensive RFP process in securing the right technology and team for the state's needs," said Steven Siegel, CEO, BioTrackTHC. "Our experience implementing compliance technology in this sector will serve the state and the public well in maintaining a reliable and efficient regulatory infrastructure."

The New Mexico Medical Cannabis Program (MCP) was created under the Lynn and Erin Compassionate Use Act to allow for the beneficial use of medical cannabis in a regulated system. In pursuit of its mission, the MCP issued an extensive RFP on July 22, 2014 for a software solution to maintain regulatory compliance.

After extensive proposal evaluations and live software demonstrations, BioTrackTHC achieved a marijuana industry first: back-to-back government contract wins.

New Mexico: Steep Hill Receives First Provisional Approval For Lab Cannabis Testing

SteepHill(logo)

Steep Hill, which specializes in cannabis testing and analytics in the United States and internationally, has announced intends to open a full service medical cannabis quality assurance laboratory in Albuquerque, New Mexico, bringing advanced scientific tools and methodology to the state, for regulatory oversight of cannabis.

Steep Hill is currently the only laboratory licensed by the New Mexico Department of Health to conduct potency and contaminant testing in order to meet the recently adopted regulatory requirements pertaining to cannabis safety for medical patients in New Mexico, according to a prepared statement from the company.

"We are excited to bring our entire suite of products to New Mexico, including our QuantaCann2™ - an advanced cloud-based potency monitoring system," said David Lampach, CEO and cofounder of Steep Hill. "This will enable the state to meet its THC and CBD testing requirements, while also providing regulators with a real time window into the marketplace."

The State of New Mexico requires regular testing be done in a Department of Health approved laboratory as the only acceptable method to determine the quality, purity and potency required for the sale of medical cannabis products.

For more information about cannabis testing, you can visit the Steep Hill website: http://steephill.com

About Steep Hill

Syndicate content